Research progress on siRNA delivery with nonviral carriers

Yan Gao*, Xin-Ling Liu*, Xiao-Rong LiTianjin Medical University Eye Center, Tianjin, China *These two authors contributed equally to this workAbstract: RNA interference is a powerful method for the knockdown of pathologically relevant genes. Small interfering RNAs (siRNAs) have been widely demonstra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gao Y, Liu XL, Li XR
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/f7dd0a7eb2154d4e89d92a029a839ab6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Yan Gao*, Xin-Ling Liu*, Xiao-Rong LiTianjin Medical University Eye Center, Tianjin, China *These two authors contributed equally to this workAbstract: RNA interference is a powerful method for the knockdown of pathologically relevant genes. Small interfering RNAs (siRNAs) have been widely demonstrated as effective biomedical genetic-therapy applications for many diseases. Unfortunately, siRNA duplexes are not ideal drug-like molecules. Problems hindering their effective application fundamentally lie in their delivery, stability, and off-target effects. Delivery systems provide solutions to many of the challenges facing siRNA therapeutics. Due to some fatal disadvantages of viral vectors, nonviral carriers have been studied extensively. Aside from liposomes, nanoparticles and cationic polymer carriers have exhibited improved in vivo stability, better biocompatibility, and efficiency for gene silencing with less cellular toxicity. They may represent a promising strategy for siRNA-based therapies, especially as nanomaterials. The present review also summarizes other methods of siRNA delivery and the side effects of the nanoparticles.Keywords: small interfering RNA, nonviral vector, gene therapy, delivery system, nanoparticles, biocompatibility